Nutrition, Metabolism and Cardiovascular Diseases
Nutrition, Metabolism and Cardiovascular Diseases is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology, Diabetes and Metabolism with an H index of 125. It has an SJR impact factor of 1,098 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,098.
Nutrition, Metabolism and Cardiovascular Diseases focuses its scope in these topics and keywords: disease, adiposity, protein, glucose, ginseng, intake, consumption, markers, activity, arterial, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
1,098
H-index
125
Docs (year)
331
Docs 3y
983
Total refs
14119
Cites 3y
3619
Citable 3y
945
Cites/Doc 2y
3.64
Ref/Doc
42.66
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
20 BALANCE BETWEEN CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCs) AND MATURE CIRCULATING ENDOTHELIAL CELLS (CECs) IN RELATION TO THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE
View moreWeight loss but not gains in cardiorespiratory fitness after exercise-training predicts improved health risk factors in metabolic syndrome
View more9 CARDIOVASCULAR RISK IN CHILDREN: APOB/APOA-I AND NON-HDL-CHOLESTEROL
View more8 THE METABOLIC SYNDROME DOES NOT ADD TO CAROTID ATHEROSCLEROSIS BEYOND THAT EXPECTED BY RISK FACTOR COUNTING OR RISK SCORING
View more6 CYTOKINE AND RECEPTOR PATTERN OF ACTIVATED VERSUS REGULATORY T CELLS IN CORONARY ARTERY DISEASES
View more5 CYTOKINE/CHEMOKINE DIFFERENTIATION PATTERN IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) ASSOCIATED WITH HIGH LEVELS OF CIRCULATING IL-6: EIGHTEEN CYTOKINES/CHEMOKINES ANALYZED SIMULTANEOUSLY WITH THE FLEX-SET CAPTURE BEAD ASSAY (CBA)
View more4 CHRONIC USE OF LIGHT OR REGULAR CIGARETTES AND FLOW MEDIATED DILATION
View more3 ARTERIAL STIFFNESS IN OBESE PATIENTS WITHOUT CARDIOVASCULAR RISK FACTORS
View more27 METABOLIC EFFECT OF A SEQUENTIAL TRAINING PROGRAM ON HYPERTENSIVE OVERWEIGHT PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
View more25 LONG-TERM EFFECTIVENESS AND SAFETY OF A NUTRACEUTICAL BASED APPROACH TO REDUCE CHOLESTEROLEMIA IN STATIN INTOLERANT SUBJECTS WITH AND WITHOUT METABOLIC SYNDROME
View more23 MODIFICATIONS OF RETICULOCYTES AND RETICULATED PLATELETS IN SEDENTARY HEALTHY MEN AFTER AN ACUTE EPISODE OF STRENUOUS EXERCISE
View more22 RETICULATED PLATELETS AND PLATELET REACTIVITY IN RENAL TRANSPLANT RECIPIENTS ON ANTIPLATELET THERAPY
View more21 DIFFERENT PATTERN OF MODIFICATIONS FOR HAEMATOPOIETIC AND ENDOTHELIAL PROGENITOR CELLS AFTER A STRENUOUS EXERCISE IN SEDENTARY HEALTHY MEN
View more1 DIAGNOSTIC AND CLINICAL ASPECTS OF CHILDREN AFFECTED BY PRIMARY DYSLIPIDEMIA
View more2 EFFECT OF PROBUCOL DERIVATE SUCCINOBUCOL (AGI-1067) ON CELLULAR CHOLESTEROL EFFLUX PATHWAYS
View more19 LIGHT AND REGULAR CIGARETTES CONSUMERS AND ENDOTHELIAL DYSFUNCTION
View more18 INFLAMMATORY AND REMODELING MARKERS IN AORTIC VALVE DISEASE: ROLE OF MMPS, TIMPS, OPN AND GGT IN LESION DEGENERATION
View more17 p66shc GENE EXPRESSION IS INCREASED IN ESRD PATIENTS ON HEMODIALYSIS: RELATIONSHIPS TO SYSTEMIC OXIDATIVE STRESS, INFLAMMATION AND CLINICAL PARAMETERS
View more16 IMPLICATION OF COMPUTER-AIMED STRATEGIES ON THE OPTIMAL MANAGEMENT OF CV RISK PROFILE IN TYPE 2 DIABETIC PATIENTS: THE "DIETA" PROJECT
View more15 LIVER FAT IS INCREASED IN TYPE 2 DIABETES INDEPENDENTLY OF VISCERAL FAT AND INSULIN-SENSITIVITY
View more14 T940M SUBSTITUTION IN ABCA1 TRANSPORTER: A NEW DOMINANT NEGATIVE MUTATION?
View more13 INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA
View more12 VASCULAR AND METABOLIC ACUTE EFFECTS OF ROSUVASTATIN COMPARED TO SIMVASTATIN IN UNTREATED DYSLIPIDEMIC DIABETIC PATIENTS
View more11 EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE DOSE OF SIMVASTATIN IN HIGH CV RISK DIABETICS NOT AT LDL-C TARGET WITH SIMVASTATIN ALONE: A DOUBLE-BLIND, RANDOMIZED ITALIAN STUDY
View more